02.08.2010 - Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)